LifeMD, Inc.
Close on Oct 19, 2026
- Market cap
- $107.52M
- P/E (TTM)
- –
- Dividend yield
- –
About LifeMD
Services-Offices & Clinics of Doctors of Medicine, SIC 8011
LifeMD, Inc. operates as a direct-to-patient healthcare company that provides virtual medical care and pharmacy services. The company delivers clinical consultations alongside prescription and over-the-counter treatments across various health areas, including primary care, men's and women's health, hormone therapy, weight management, insomnia, dermatology, and cardiology. Most offerings follow a subscription model, serving individual patient subscribers directly.
The company operates across the United States through an affiliated medical provider network licensed in all 50 states, supported by a nationwide pharmacy network, diagnostic integrations, and an integrated patient care center. It maintains a wholly-owned commercial pharmacy facility to handle prescription fulfillment. LifeMD is based in the United States, with its principal executive offices located in New York, New York.
Summary of the business section of LifeMD's latest annual report, written by StockData.
Company profile
Company
- Legal name
- LifeMD, Inc.
- Headquarters
- New York, NY
- Address
- 236 Fifth Avenue, Suite 400 10001
- Phone
- (866) 351-5907
- Employees
- 389, Dec 31, 2025
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Marcum LLP, Marlton, New Jersey
Stock & identifiers
- Ticker
- LFMD
- Other tickers
- LFMDP
- Exchange
- Nasdaq
- IPO date
- Jan 29, 2008
- Shares outstanding
- 48M, Aug 4, 2026
- Public float
- $512.47M, Jun 30, 2025
- Filer category
- Accelerated filer
- Stock splits
- 1-for-5 reverse, Nov 16, 2020; 1-for-5 reverse, Oct 14, 2020
- SEC CIK
- 948320
- CUSIP
- 53216B104
- ISIN
- US53216B1044
- EIN
- 76-0238453
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Justin Schreiber | Chairman and CEO, Director | 2,703,715 |
| Umesh Sripad | Chief Technology Officer | 75,000 |
| Atul Kavthekar | Chief Financial Officer | 337,500 |
| Christopher A. Pisano | Chief Marketing Officer | 200,000 |
| Jessica Friedeman | Chief Marketing Officer | 205,000 |
| Nicholas P. Alvarez | Chief Acquisition Officer | 605,000 |
| Marc David Benathen | Chief Financial Officer | 426,554 |
| Stefan Galluppi | Chief Innovation Officer | 1,755,249 |
| Eric Harold Yecies | Chief Legal Officer & GC | 405,000 |
| Maria E. Stan | Chief Accounting Officer | 227,500 |
| Dennis Wijnker | Chief Technology Officer | 175,000 |
| Shayna Webb Dray | Chief Operating Officer | 295,000 |
| Shane Biffar | Chief Compliance Officer | 150,000 |
| John R. Strawn Jr | Director | 558,001 |
| Joan Larovere | Director | 142,050 |
| Calum Archibald Macrae | Director | 73,865 |
| Joseph DiTrolio | Director | 308,413 |
| Roberto Simon | Director | 150,000 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Mr. Schreiber | $777.08K | $777.08K | $1.55M | $52 | – |
| FY2024 Mr. Schreiber | $1.06M | $1.06M | $1.10M | $63 | – |
| FY2023 Mr. Schreiber | $888.80K | $948.30K | $2.10M | $106 | – |
| FY2022 Mr. Schreiber | $255.00K | $255.00K | $1.08M | $30 | – |
| FY2021 Mr. Schreiber | $180.00K | $180.00K | $5.86M | $59 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“of December 31, 2025, we employed 389 employees, of which 347 were full-time, 5 were part-time, and 37 were temporary employees.”
Corporate history
Events identified from SEC filings